231 related articles for article (PubMed ID: 28261787)
1. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
[No Abstract] [Full Text] [Related]
3. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.
Zhao Y; McLaughlin D; Robinson E; Harvey AP; Hookham MB; Shah AM; McDermott BJ; Grieve DJ
Cancer Res; 2010 Nov; 70(22):9287-97. PubMed ID: 20884632
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
5. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J
Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536
[TBL] [Abstract][Full Text] [Related]
7. Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity.
Lee Y; Kwon I; Jang Y; Cosio-Lima L; Barrington P
Med Sci Sports Exerc; 2020 Jan; 52(1):25-36. PubMed ID: 31318716
[TBL] [Abstract][Full Text] [Related]
8. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
[TBL] [Abstract][Full Text] [Related]
10. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
[TBL] [Abstract][Full Text] [Related]
11. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
12. Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction.
Cappetta D; Esposito G; Coppini R; Piegari E; Russo R; Ciuffreda LP; Rivellino A; Santini L; Rafaniello C; Scavone C; Rossi F; Berrino L; Urbanek K; De Angelis A
Br J Pharmacol; 2017 Nov; 174(21):3696-3712. PubMed ID: 28320043
[TBL] [Abstract][Full Text] [Related]
13. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
[TBL] [Abstract][Full Text] [Related]
14. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of valsartan administration on doxorubicin‑induced myocardial injury in rats and the role of oxidative stress and NOX2/NOX4 signaling.
Cheng D; Chen L; Tu W; Wang H; Wang Q; Meng L; Li Z; Yu Q
Mol Med Rep; 2020 Nov; 22(5):4151-4162. PubMed ID: 33000246
[TBL] [Abstract][Full Text] [Related]
16. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1.
Zhang S; Yuan Y; Zhang Z; Guo J; Li J; Zhao K; Qin Y; Qiu C
Biosci Biotechnol Biochem; 2019 Apr; 83(4):653-658. PubMed ID: 30558506
[TBL] [Abstract][Full Text] [Related]
18. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice.
Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H
Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy.
Ma Y; Zhao HP; Yang LG; Li L; Wang AL; Zhang XJ; Wang K; Yang B; Zhu ZF; Zhang PJ; Wang JP; Chi RF; Li B; Qin FZ; Wang ZP
Sci Rep; 2024 Mar; 14(1):6971. PubMed ID: 38521855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
